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http://www.biomedcentral.com/1756-0500/5/222RESEARCH ARTICLE Open AccessBone to pick: the importance of evaluating
reference genes for RT-qPCR quantification
of gene expression in craniosynostosis and
bone-related tissues and cells
Xianxian Yang1,2†, Jodie T Hatfield2†, Susan J Hinze2, Xiongzheng Mu1, Peter J Anderson2,3,4 and Barry C Powell2,4*Abstract
Background: RT-qPCR is a common tool for quantification of gene expression, but its accuracy is dependent on
the choice and stability (steady state expression levels) of the reference gene/s used for normalization. To date,
in the bone field, there have been few studies to determine the most stable reference genes and, usually, RT-qPCR
data is normalised to non-validated reference genes, most commonly GAPDH, ACTB and 18 S rRNA. Here we draw
attention to the potential deleterious impact of using classical reference genes to normalise expression data for
bone studies without prior validation of their stability.
Results: Using the geNorm and Normfinder programs, panels of mouse and human genes were assessed for their
stability under three different experimental conditions: 1) disease progression of Crouzon syndrome
(craniosynostosis) in a mouse model, 2) proliferative culture of cranial suture cells isolated from craniosynostosis
patients and 3) osteogenesis of a mouse bone marrow stromal cell line. We demonstrate that classical reference
genes are not always the most ‘stable’ genes and that gene ‘stability’ is highly dependent on experimental
conditions. Selected stable genes, individually or in combination, were then used to normalise osteocalcin and
alkaline phosphatase gene expression data during cranial suture fusion in the craniosynostosis mouse model and
strategies compared. Strikingly, the expression trends of alkaline phosphatase and osteocalcin varied significantly
when normalised to the least stable, the most stable or the three most stable genes.
Conclusion: To minimise errors in evaluating gene expression levels, analysis of a reference panel and subsequent
normalization to several stable genes is strongly recommended over normalization to a single gene. In particular,
we conclude that use of single, non-validated “housekeeping” genes such as GAPDH, ACTB and 18 S rRNA, currently
a widespread practice by researchers in the bone field, is likely to produce data of questionable reliability when
changes are 2 fold or less, and such data should be interpreted with due caution.
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To help elucidate the molecular mechanisms involved in
skull development and bone growth and the dysregula-
tion that occurs during craniosynostosis, a medical con-
dition that affects skull formation in 1 in 2500 live
births, the ability to accurately measure changes in gene
expression levels is vital. The most popular method is
that of RT-qPCR where gene expression is measured
against a reference gene. Alternatively, and less often,
“absolute” quantification is used where gene expression
is compared to an external standard and expressed rela-
tive to a biological unit, such as input RNA, cell number,
or even a reference gene [1]. No studies have been pub-
lished on the selection of suitable reference genes for
use in craniosynostosis and most gene expression profil-
ing on bone-related conditions rely on using common
normalizers such as ACTB, GAPDH and 18 S rRNA,
with little evidence of validation of their stability. Fur-
thermore, most bone studies normalize data to only one
reference gene, typically GAPDH (see Additional file 1),
considered by many as a stable housekeeping gene des-
pite substantial evidence to the contrary [1].
There is an increasing call to assess reference genes
for stability in sample sets for each new experiment to
avoid producing misleading data, particularly where the
magnitudes of the gene expression changes are small. To
address these concerns, a set of guidelines have been
proposed; MIQE, minimum information for publication
of quantitative real-time PCR experiments [2]. These
guidelines invite a transparency in reporting so that the
quality of data can be judged on several criteria such as
experimental design, RNA quality control, normalization
strategy and validation, data analysis and applied statis-
tics. Unfortunately, recent studies published in the bone
field indicate a widespread practice of reliance on nor-
malising gene expression to non-validated, single gene
references (see Additional file 1) and are indicative that
there is insufficient awareness and appreciation of asso-
ciated pitfalls.
In this study we investigated three common biological
tools for studying osteogenesis and craniosynostosis in
the laboratory; primary human cranial suture cells from
affected patients, a mouse model of craniosynostosis and
a mouse cell line to model osteogenesis and mineralisa-
tion in culture. Twelve candidate reference genes for
human and mouse samples were chosen and assessed
for stability using geNorm and Normfinder software.
geNorm software uses geometric averaging of expression
of a defined number of genes in a given cDNA sample
set and determines the rank order of their relative sta-
bility [3] whereas Normfinder takes a “model-based
approach” where input data is organised into groups (e.g.
wildtype vs. mutant) and gene expression stability esti-
mates take into account inter- and intragroup variations[4]. We compared the effect of normalizing data based
on the least stable, most stable, and multiple stable
reference genes for two common markers of osteogen-
esis, alkaline phosphatase (ALP) and osteocalcin (OC).
Our results indicate substantial variability in the com-
monly used single housekeeping genes, GAPDH, ACTB
and 18sRNA across three experimental bone models
and highlight the importance of validating and choosing
the most appropriate combination of reference genes for
each experimental dataset to avoid erroneous report-
ing of changes in gene expression levels in studies of
bone biology.
Results
Selection of stable reference genes
Our panel of reference genes included members from dis-
tinct cellular pathways (i.e. less likely to be co-regulated)
as well as classical housekeeping genes. RNA panels were
selected to represent typical experiments in a bone lab:
1) mouse cranial suture tissues from Fgfr2cC342Y/+ mice
harboring a Cys342Tyr replacement frequently observed
in human Crouzon and Pfeiffer-type craniosynostosis,
2) cultured primary human cranial suture cells from cra-
niosynostosis patients, and 3) a mouse osteoblastic cell
line induced to mineralize over 21 days in culture
(Table 1). Mineralisation was verified by the accumulation
of Alizarin red S in induced samples relative to uninduced
samples (Additional file 2). RNAs representative of each
panel were chosen for geNorm and Normfinder analysis.
RT-qPCR analysis
RT-qPCR data was analyzed using geNorm software to
obtain a stability value (M) for each reference gene and
the mean pairwise variation value (V) in a sample set.
Genes with the lowest M values were considered the
most stable, while the V value indicated the optimal
number of genes to use for normalization. The same
data was then analysed with Normfinder and the two
approaches compared. Stabilities of reference genes in
our sample panels are shown in Additional files 3 and 4
and summarized in Table 2.
In our first test panel we determined the most stable
reference genes in craniosynostosis-related suture mater-
ial from a commonly used mouse model for Crouzon
syndrome. The geNorm rank order data analysis indi-
cated that Cyc1, Gapdh and Canx were the most stable
combination of reference genes to use, while 18 S rRNA
gene had the highest variability (Table 2; Additional
file 3). Normfinder also ranked 18 s rRNA as one of the
least stable genes and Canx as one of the most stable,
with Cyc1 and Gapdh ranked towards the middle
(Table 2; Additional file 4). It proposes the use of Ubc
and Canx as the most stable normalisation factor, and
we note that Ubc is also considered an adequately stable
Table 1 RNA sample list
Mouse suture tissues
Time point Genotype Suture type
E16.5 * Wildtype Coronal, Posterior-frontal, Lambdoid, Parietal bone
D0 # Wildtype Coronal, Lambdoid
D0 Fgfr2cC342Y/+ Posterior frontal, Sagittal
D1 Fgfr2cC342Y/+ Coronal, Lambdoid
D5 Wildtype Lambdoid, Parietal bone
D5 Fgfr2cC342Y/+ Posterior frontal, Sagittal
D10 Wildtype Coronal, Lambdoid
D10 Fgfr2cC342Y/+ Posterior-frontal, Sagittal
Human suture cells
Patient code Phenotype Sex Age (months) Suture type Passage
AC 125 Sagittal synostosis M 7 Unfused Coronal P5, P10
AC 124 Metopic synostosis M 7 Unfused Coronal P4, P8
AC 126 Metopic synostosis F 9 Unfused Coronal P4
AC 141 Sagittal synostosis M 6 Unfused Coronal P3
AC 125 Sagittal synostosis M 7 Unfused Lambdoid P4
AC 120 Crouzonoid syndrome F 96 Fused Sagittal P9
AC 113 Multi-suture synostosis F 10 Fused Coronal P5
AC 34 Multi-suture synostosis F 5 Fusing Sagittal P5
Kusa 4b10 - Osteogenesis assay+






*E refers to embryonic day.
#D refers to postnatal day.
+days after induction or days after the equivalent time point for uninduced cells.
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off proposed by Vandesompele et al (2002).
We next determined if stability differed when switch-
ing to a different but related sample background, as it is
a common laboratory habit to use the same “housekeep-
ing” gene for all purposes, regardless of species, tissue
source or process. Our second panel consisted of human
cells sourced from the cranial sutures of craniosynostosis
patients that have been subsequently cultured in vitro.
Again geNorm ranked CYC1 and GAPDH among the
most stable genes, but they were superseded by 18 S
rRNA and ATP5B, which were considered sufficient for
reliable normalization (Table 2; Additional file 3). Norm-
finder also ranked 18 S rRNA and ATP5B among the
most stable genes but recommended a combination of
18 S RNA and SF3A1 for normalization (Table 2; Add-
itional file 4). It was striking that 18 S rRNA was the
most stable gene in the human cells whereas in mouse
tissue it was the least stable. Significantly, anothercommonly used reference gene, ACTB, was ranked
the least stable by both geNorm and Normfinder in
the human cranial cells. We also noted that GAPDH
was ranked very differently by the different software
(geNorm – more stable, Normfinder – less stable) and
assume this is a result of the different approaches each
program takes.
In our final test panel we looked at the stability of our
reference genes during terminal cell differentiation by
following osteogenesis of the Kusa 4b 10 cell line over
21 days in culture. Genes Cyc1 and Eif4a2 were excluded
from this analysis because of low abundance indicated
by poor amplification. The two most stable genes, as
determined by geNorm, were Canx and 18 S rRNA,
which were ranked as sufficient for reliable nor-
malization among the remaining 10 candidate genes
(Table 2; Additional file 3). Atcb was amongst the more
stable genes while Gapdh was amongst the least stable.
Normfinder rankings in this case are almost identical to
Table 2 Summary of geNorm and Normfinder gene stability values
Mouse suture tissues Human suture cells Kusa 4b 10 cells
geNorm Normfinder geNorm Normfinder geNorm Normfinder
18 S rRNA 0.95 Eif4a2 0.477 ACTB 0.77 ACTB 0.716 Rpl13a 0.67 Gapdh 0.249
Eif4a2 0.84 18 S rRNA 0.390 EIF4A2 0.67 EIF4A2 0.687 Gapdh 0.62 Rpl13a 0.237
Sdha 0.75 Atp5b 0.340 SDHA 0.63 GAPDH 0.465 B2m 0.56 B2m 0.200
Rpl13a 0.67 Sdha 0.315 B2M 0.60 SDHA 0.461 Sdha 0.50 Sdha 0.184
B2m 0.63 Cyc1 0.289 TOP1 0.57 TOP1 0.422 Ywhaz 0.48 Ywhaz 0.135
Actb 0.59 Ywhaz 0.274 RPL13A 0.53 B2M 0.348 Ubc 0.44 Canx 0.097
Atp5b 0.55 Actb 0.255 SF3A1 0.49 CYC1 0.337 Actb 0.42 Ubc 0.091
Ywhaz 0.52 Gapdh 0.224 YWHAZ 0.41 YWHAZ 0.337 Atp5b 0.39 Actb 0.086
Ubc 0.49 Rpl13a 0.194 CYC1 0.36 ATP5B 0.295 Canx* 0.35 Atp5b 0.074
Canx 0.47 B2m 0.188 GAPDH 0.31 18 S rRNA 0.262 18 s rRNA* 0.35 18 S rRNA 0.048
Cyc1* 0.34 Ubc 0.141 18 S rRNA* 0.28 RPL13A 0.217
Gapdh* 0.34 Canx 0.081 ATP5B* 0.28 SF3A1 0.202
Genes are ranked from the least stable (top) to the most stable (bottom). Stability values are shown for geNorm and Normfinder and lower numbers indicate
greater stability. Asterisk indicates equal ranking. The optimal number of reference genes to use, based on their V values (geNorm) or intergroup/intragroup
variations (Normfinder) are marked as bold.
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stable and Gapdh as the least stable of the 10 genes
(Table 2; Additional file 4). It recommends a nor-
malization factor based on 18 S rRNA and Atp5b.
Expression patterns of two common markers of
osteogenesis were significantly affected by the
normalization strategy
To put the ranking analysis data into an experimental
context we investigated the effect of reference gene se-
lection on the expression profiles of two commonly used
marker genes for bone development and mineralisation,
OC and ALP. OC is a marker of terminally differentiated
osteoblasts during osteogenesis and osteoblastogenesis
[5,6], while ALP is a marker of early stage osteoblast dif-
ferentiation [7,8]. Using RNA from cranial sutures of
Fgfr2cC342Y/+ mice and their wildtype littermates, we
expected to see an increase in OC and ALP expression
during post-natal suture development [9,10]. Further-
more, as coronal sutures remain patent in wildtype mice
and undergo premature bony fusion in Fgfr2cC342Y/+
mice, we also expected these genes to be differentially
expressed between the two groups.
From the geNorm analysis of the mouse suture panel
we applied Canx (one of the most stable genes), 18 S
rRNA (least stable gene) or Cyc1-Gapdh-Canx (recom-
mended gene combination for normalization) as refer-
ences for relative quantification of OC and ALP during
suture fusion of Fgfr2cC342Y/+ mice and their wildtype lit-
termates (Figure 1). We chose the geNorm rankings over
the Normfinder rankings as geNorm was conveniently
integrated into the qBasePLUS analysis software that
was used to handle the many calculations required [11].However, we note that Normfinder also ranks Canx as
the most stable gene and 18 S rRNA as second least
stable gene.
Using any of the three normalizers, OC expression
increased with age and showed no significant differences
between the wildtype and mutant mice (Figure 1a-c).
However, the use of 18 S rRNA as the normalizer (least
stable) resulted in a day 10 expression level that was
approximately one third of that calculated by the other
two strategies (Figure 1g).
Results for ALP expression also indicated a general
increase in expression levels with age for all three nor-
malisation strategies (Figure 1d-f ). Using the three gene
reference set, the results indicated that coronal sutures
from Fgfr2cC342Y/+ mice expressed significantly more
ALP than their wildtype counterparts for three of the
four time points investigated. In contrast, ALP gene
expression data generated using the 18 S rRNA reference
(the least stable), identified only Day 0 samples as
significantly different and analysis based on the Canx
reference (the most stable) indicated two significant dif-
ferences. This outcome most likely reflects the small fold
changes between the mutant and wildtype data points.
We conclude that when judging the significance of
values separated by a two fold change or less, small
fluctuations in the data caused by the choice of nor-
malization strategy can lead to significantly different out-
comes and interpretations (Figure 1h).
Based on the use of the recommended normalisation
strategy, our data indicates that Fgfr2cC342Y/+ mice have
slightly elevated levels of ALP compared to their wild-
type counterparts. Interestingly, although this suggests
a possible increase in the number or activity of cells
Figure 1 Comparison of normalization strategies on expression of two common osteogenesis markers. Relative quantification of OC
and ALP expression during suture fusion in Fgfr2cC342Y/+ mice is dependent on which reference genes are used. Target gene expression was
normalized to the geometric mean of Cyc1 - Gapdh - Canx (a and d), the single most stable gene - Canx (b and e) or the least stable gene – 18 S
rRNA (c and f). Relative gene expression in wildtype sutures, normalized to the different reference genes, is also presented (g and h). Expression is
displayed as fold change relative to day 0 wildtype. N = 6. * Represents a significant difference between two groups ( p < 0.05). # Represents a
significant difference to Day 0 WT value (p < 0.05).
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significant change in levels of the terminal differentia-
tion marker OC between mutant and wildtype. Bio-
logical significance aside, it is clear to see that the
normalization strategy has a strong influence over the
magnitude (see OC) and number of significantly differ-
ent data points (see ALP). Had we relied on 18 S rRNA
as the reference gene, we would have reported only a 10
fold increase in OC expression by day 10 (instead of
~30) but, more importantly, the significant differences in
ALP expression between wildtype and mutant would not
have been detected.Discussion
Traditionally, RT-qPCR has relied on normalization of
gene expression levels to only one of a few housekeeping
genes which were originally, and incorrectly, thought to
be universally expressed at a steady-state level eg. ACTB,
18 S rRNA and GAPDH. Recently, this trend has begun
to slowly change due to reports of the need to carefully
select validated reference genes to avoid generating
biased data due to variation in the reference gene’s
expression pattern [2,3], [11]. However, our brief survey
of the bone field indicates the practice of using a single,
non-validated reference gene, typically GAPDH (followed
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we demonstrated that reference genes for normalizing
data related to bone growth and craniosynostosis studies
cannot be used interchangeably for different experimen-
tal situations, even if the samples are biologically similar.
Notably, we found that the expression of GAPDH, ACTB
and 18 S rRNA genes changed the most between sample
panels, indicating that of all the genes examined they
were the least predictable in terms of stability. A recent
geNorm-based study by Di et al (2011) confirms the vari-
ability of these three genes in other bone cell culture
models although the authors did not investigate the
potential adverse effects that might occur if nor-
malization is restricted to one of those typical house-
keeping genes [12].
Several studies show that when normalizing expression
data, noticeable variations are produced by substituting
different reference genes [13-17]. In mouse cranial
suture tissue samples, we demonstrated the extent of
this effect in a bone-specific context by using three
normalization strategies to determine the expression
levels of two common markers of osteogenesis and
mineralization, OC and ALP. Expression of OC and ALP
are regularly used as measures of osteogenesis and min-
eralisation and, as we have shown, use of even the single
most stable reference gene can substantially bias data
analysis, particularly when making judgements on the
significance of low order magnitude changes (e.g. 2 fold).
It is therefore of great concern that, based on our survey
of the bone field, many recent studies of endochondral
ossification have concluded significant changes in gene
expression at a level of 2 fold or less based on the non-
validated use of GAPDH, one of the most variable genes
and amongst the least stable of genes in our cell culture
studies in an endochondral ossification model.
Observation of the trends in any one of our three
panels for OC or ALP expression in isolation would not
necessarily indicate problematic data. Without prior
knowledge of the ranking order provided, in this case by
geNorm analysis, the observer would not be able to con-
fidently select which strategy to use. Even selecting the
single most stable reference gene, while a reasonable
alternative when assessing OC expression, would be a
poor choice for ALP expression.
There are currently three methods available for esti-
mating reference gene expression stability based on ex-
perimental data, geNorm, Normfinder and Bestkeeper,
and a fourth source, RefGenes, based on microarray data
[3,4,18,19]. The two most popular (based on citation)
are geNorm and Normfinder, which we compared in this
study. In general, both programs identified the same
genes as least stable and most stable although the indi-
vidual ranking orders differed. This was not unexpected
as the programs use two different approaches in order torank gene expression stability. We can conclude that
either program will generate a good starting point for
selecting genes to use in normalization, but as we
have shown here and as stated in the original articles for
both geNorm [3] and Normfinder [4], generating a
normalisation reference to multiple genes should always
be considered.
Detection of gene expression changes during bone
growth or disease progression can be a useful means of
predicting outcomes for these processes. In theory, stud-
ies that can show significant up or down regulation of
genes before the onset of gross morphological changes
seen in craniosynostosis (fusing sutures) can help to
identify important pivotal genes. Furthermore, the early
detection of altered gene expression can help to pinpoint
appropriate intervention times for applying new treat-
ments. As shown in this study, the accuracy of this
type of data is heavily dependent on choosing an appro-
priate normalisation strategy. The use of biased results,
based on misleading trends or fold changes, could lead
to misguided research and mistaken assessment of cause
and effect.Conclusions
We strongly recommend that gene expression data be
normalized to at least two validated reference genes.
These could be determined by a geNorm-style selection
process from a panel of candidate genes. In particular,
we conclude that use of non-validated “housekeeping”
genes such as GAPDH, ACTB and 18 S rRNA, currently
a widespread practice by researchers in the bone field, is
likely to produce data of questionable reliability when
changes are 2 fold or less, and such data should be con-
sidered with due caution.Methods
Mouse suture tissues
Suture samples were collected from Fgfr2cC342Y/+ x Swiss
mice offspring (E16.5, 0, 1, 5 and 10 day old mice). The
posterior frontal, sagittal, coronal and lambdoid sutures
were excised from the calvaria, leaving a thin strip
of bone less then 1 mm along each side of the suture.
Parietal bone was also collected. Pericranium and dura
mater were dissected free and RNA extracted. Genotyp-
ing PCR on tail DNA (QIAGEN blood and tissue kit,
Doncaster, Victoria, Australia) used primers 5’-CAAG-
CAAGCTCAACAGGAGAG-3’ and 5’-GCTGTGCTG-
CTGAGAGTTTTG-3’ producing a 224 bp wildtype
amplicon or a 290 bp mutant amplicon. Adult C57Bl/6
skull, liver and brain and 3 week old femoral and tibial
bones were processed for RNA. Work was approved by
the Animal Ethics Committee, Children’s, Youth and
Women’s Health Service, SA.
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Human cranial suture cells were isolated from seven
patients undergoing transcranial surgery for syndromic or
non-syndromic craniosynostosis. Consent was obtained
following the guidelines of the Research Ethics Committee
of the Children, Youth and Women’s Health Service, SA.
Patients were genotyped for mutations in FGFR1-3 and
TWIST [20]. Primary suture cells were obtained by col-
lagenase digestion and explant culture [21]. Cells from dif-
ferent suture types and fusion states were used (Table 1).
Cells were collected for RNA at various passages.
Mouse Kusa 4b 10 cells
The Kusa 4b 10 bone marrow stromal cell line [22] was
maintained in alpha MEM (Invitrogen, Sydney, Austra-
lia) supplemented with 10 % heat-inactivated fetal bovine
serum (FBS, Invitrogen), 100 IU/ml penicillin and
100 IU/ml streptomycin (Sigma-Aldrich, Sydney, Australia).
For osteogenesis, 5000 cells at P20 were plated in tri-
plicate and induced the next day by addition of 10 mMTable 3 geNorm housekeeping gene selection kit candidates
Gene Symbol Gene Name





Rpl13a Ribosomal protein L13A
Cyc1 Cytochrome c-1
Sdha Succinate dehydrogenase comp
18 S rRNA 18 S ribosomal RNA
Eif4a2 Eukaryotic translation initiation fa
Atp5b ATP synthase subunit 5B
Ubc Ubiquitin C
Canx Calnexin





RPL13A Ribosomal protein L13A
CYC1 Cytochrome c-1
SDHA Succinate dehydrogenase comp
EIF4A2 Eukaryotic translation initiation fa
18 S rRNA 18 S ribosomal RNA
ATP5B ATP synthase subunit 5B
SF3A1 Splicing factor 3 subunit 1
TOP1 DNA topoisomerase 1β-glycerophosphate supplemented growth media (alpha
MEM, 15 % FBS, 50 μg/mL ascorbic acid, 100 IU/ml
penicillin and 100 IU/ml streptomycin) exchanged every
three days for 21 days. Cells were either collected for
RNA or fixed and stained with 0.1 % Alizarin red S solu-
tion (Sigma-Aldrich). Alizarin dye was destained and
quantified at A450.
RNA isolation and cDNA synthesis
Total RNA was extracted using Trizol (Invitrogen) with
modifications for mouse suture and bone tissues as fol-
lows: tissues were homogenized in liquid nitrogen and
RNA precipitation was aided by addition of glycogen.
RNA pellets were reconstituted at 60°C for 10 min. For
embryonic mouse suture samples, two mice of the same
genotype were combined. For all samples, RNA quality
was checked on a 1 % agarose gel and concentrations
and A260/A280 ratios determined.
Total RNA (500 ng for mouse suture tissues, 250 ng
for human suture cells and 1 μg for Kusa 4b 10 cells andPathway/Process
cytoskeletal protein





lex subunit A citric acid cycle
protein synthesis










lex subunit A citric acid cycle
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amers (Superscript III first strand synthesis kit, Invitro-
gen). cDNA samples were diluted 1:3 in RNase/DNase
free water before use in PCR; human suture cell cDNAs
were diluted 1:4; Kusa 4b 10 cell cDNAs and adult tis-
sues were diluted 1:10. No-RT controls were made for all
mouse RNA samples by replacing Superscript III with
RNase/DNase free water during the RT step. Representa-
tive no-RT controls were made for the human samples.
geNorm/Normfinder Assays
geNorm assays were carried out using either the mouse
or human geNormTM Housekeeping Gene Selection Kit
(PrimerDesign Ltd, Southampton, UK). Genes are listed
in Table 3. We chose this kit as the primer assays were
guaranteed by the company to have high efficiencies, the
gene group included members from distinct cellular
pathways (i.e. less likely to be co-regulated) and they
included a number of classical housekeeping genes
which are in common use in the bone field and which
were therefore important to assess. Kusa 4b 10 PCR
assays used 5 μl cDNA, 0.12 μl 100×SYBR green
(Thermo Fisher Scientific, Victoria, Australia), 2 μl
10×PCR Buffer (Applied Biosystems, Victoria, Australia),
2 μl 25 mM MgCl2 (Applied Biosystems), 0.2 μl 10 mM
dNTPs (Invitrogen), 300 nM primers (PrimerDesign
Ltd), 5 U/μl AmpliTaqGold DNA polymerase (Applied
Biosystems) to a final volume of 20 μl. Cycling condi-
tions were as follows: an initial 95°C step for 10 min,
then 40 cycles of 95°C for 15 s and finally 60°C for 60 s.
KAPA SYBR FAST qPCR Master Mix (Kapa Biosystems,
Woburn, MA, USA) was used for mouse suture tissue
and human suture cells assays. 10 μl qPCR reactions
contained 5 μl 2×Kapa Master Mix, 0.5 μl gene specific
20×primer mix, 1.43 μl cDNA (diluted 1:3 or 1:4) and
3.07 μl RNase/DNase free water. The thermal profile
was 95°C for 3 min followed by 40 cycles of 30 s at 95°C
and 25 s at 60°C. All samples were assayed in duplicate,
including no template controls (NTCs), on a Rotor-
Gene 6000 Real-time PCR machine (Qiagen). Melt curve
analysis, gel electrophoresis and sequencing were used
to verify product identity. For stability comparisons of
candidate reference genes, geNorm software version 3.5
and Normfinder was used [3,4].
Evaluation of selected reference genes in a mouse
craniosynostosis study
RT-qPCR was carried out on 48 mouse coronal suture
tissue samples collected from 6 wild-type and 6
Fgfr2cC342Y/+ mice at days 0, 1, 5 and 10. Gene expres-
sion was measured for OC (Forward: 5’-ACCTCACA
GATGCCAAGCC-3’, Reverse: 5’-ATCTGGGCTGGG
GACTGAG-3’) and ALP (Forward: 5’-GGGACGAAT
CTCAGGGTACA-3’, Reverse: 5’-AGTAACTGGGGTCTCTCTCTTT-3’) and normalized to the most stable, the
three most stable or the least stable reference gene(s)
using qBasePLUS software (Biogazelle, Ghent, Belgium)
[11]. Standard curves were obtained for each assay show-
ing the qPCR reaction efficiency to be 100± 5 % and
were included in calculations.
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Additional file 3: Reference gene stability ranking in three
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